In this interview, Dr. Marsh Durban explores how innovations such as controlled seeding and size‑selection are enabling researchers to generate uniform, assay‑ready organoids at scale.

Today, Molecular Devices, LLC., a leading high-performance life science solutions provider, officially opened its custom-built site in Cardiff, UK. The multi-million-pound facility was custom-built ...

Stay up to date on the latest science with Brush Up Summaries. Finally, although transgenic animals and mammalian cell culture systems promote optimal expression due to correct protein modifications, ...

Southwest Research Institute (SwRI) has demonstrated a new application for its cell-expansion bioreactor to advance tissue engineering and cell-based therapies for treatment of injuries and diseases.

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Schematic of a typical bioreactor. Key components include the reactor tank, agitation system, feeding pump, thermal jacket, submerged aerator, and sensor probes for monitoring and maintaining optimal ...

Monoclonal Antibody Production System: The Cell-Pharm System 100 is designed for research-scale production of monoclonal antibodies, viruses, and recombinant proteins in a benchtop operation. It is ...

Regulatory approval is only one marker of success for biotherapeutics. Biotherapeutics must also be commercially feasible. Too high a price tag can lead to limited availability to the targeted patient ...

One major challenge lies within the solid tumor microenvironment (TME), where immunosuppressive cytokines can hinder the tumor-killing activity of T-cells. As a result, the TME plays a critical role ...

Steve Abel, an associate professor in the Department of Chemical and Biomolecular Engineering at the University of Tennessee, Knoxville, has spent more than a decade using computational and ...